SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 34.12 |
Enterprise Value ($M) | 3.50 |
Book Value ($M) | 88.73 |
Book Value / Share | 6.29 |
Price / Book | 0.38 |
NCAV ($M) | 87.01 |
NCAV / Share | 6.17 |
Price / NCAV | 0.39 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.32 |
Return on Assets (ROA) | -0.81 |
Return on Equity (ROE) | -1.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 12.73 |
Current Ratio | 12.73 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 95.96 |
Assets | 97.69 |
Liabilities | 8.95 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.42 |
Operating Income | -29.26 |
Net Income | -28.45 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -25.34 |
Cash from Investing | -57.35 |
Cash from Financing | 82.39 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Citadel Advisors Llc | 8.50 | ||
13G/A | Soleus Capital Master Fund, L.P. | 5.00 | -20.99 | |
13D | AI Biotechnology LLC | 19.99 | ||
13G | Cormorant Asset Management, LP | 9.99 | ||
13G | Eventide Asset Management, Llc | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,744 | 76,484 | 6.20 | |
12,674 | 16,526 | 76.69 | |
4,588 | 8,550 | 53.66 | |
6,098 | 5,789 | 105.34 | |
(click for more detail) |
Similar Companies | |
---|---|
VTGN – Vistagen Therapeutics, Inc. | VTVT – vTv Therapeutics Inc. |
VXRT – Vaxart, Inc. | WINT – Windtree Therapeutics, Inc. |
XBIO – Xenetic Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io